Latest Emergency contraception Stories

2010-04-17 15:20:56

AUSTIN, Texas -- American women who live along the U.S.-Mexico border frequently buy over-the-counter oral contraceptives from Mexican pharmacies because they don't need a prescription and can send a friend to pick up the pills, according to a study by researchers from two University of Texas campuses and Ibis Reproductive Health. The research, conducted in the El Paso-Juarez area, suggests there is demand in the United States for over-the-counter birth control pills and that many U.S....

2010-03-17 08:59:54

No increase in unprotected sex Providing emergency contraception to women in advance of need does not reduce pregnancy rates, despite increased use and faster use after unprotected sexual intercourse. These are the findings according to a new review published in The Cochrane Library. Women who take emergency contraception up to five days after unprotected sex are less likely to become pregnant. But there are many reasons why women may not be able to access emergency contraception within this...

2010-03-09 14:50:26

Swedish scientists are touting both the safety and effectiveness of home-based abortion medications for women who are 50 to 63 days pregnant, according to a March 9, 2010 Reuters report. Researchers at the Karolinska Institutet in Stockholm, led by Dr. Helena Kopp Kallner, state that this is the first survey to look at the use of the home-based procedure beyond 49 days post-conception. The procedure requires women to take a dose of mifepristone (also known as RU-486), followed three to four...

2010-02-01 07:00:00

MORRISTOWN, N.J., Feb. 1 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) and HRA Pharma today announced an exclusive licensing agreement for Watson to become the commercial partner for ulipristal acetate (UPA), a selective progesterone receptor modulator in the U.S. UPA is a novel next-generation emergency contraceptive developed by HRA Pharma specifically for emergency contraceptive use that is approved and marketed by HRA Pharma in Europe as ellaOne®...

2010-01-29 13:50:00

The first morning after pill which can be taken up to five days after sex is raising concerns that it could promote promiscuity and trigger a rise in sexually transmitted diseases. EllaOne can be taken up to 48 hours later than the current tablet. It is also potentially more effective, a new study shows, reducing the small risk of pregnancy in women who take the pills by around half. A study was conducted on about 1,700 women ages 16 to 36 who took the emergency contraception 3 to 5 days...

2009-11-02 00:30:00

TOKYO, November 2 /PRNewswire-FirstCall/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), the biopharmaceutical company, today announced that Sosei Co., Ltd., its wholly owned Japanese subsidiary, has entered into a definitive distribution agreement with ASKA Pharmaceuticals Co., Ltd. ("ASKA", TSE First Section Index: 4514) for the commercialisation of the emergency contraceptive pill SOH-075 (NorLevo(R)). NorLevo(R) is an oral emergency contraceptive "morning after...

2009-10-28 14:44:05

A European study has defined the profile for the usage of long-acting contraceptive methods. The work, presented with the National Congress of Gynecology award, shows, amongst other things, that 10% of women use these methods, the majority over 30 years old. "Long-acting contraceptives (the IUD, contraceptive injection or contraceptive implant) are still not widely used", Sergio Haimovich, researcher at the Hospital del Mar in Barcelona and author of the study published in the European...

2009-10-20 11:10:00

The condom is now as popular as the pill for UK women, newest figures say. 25% of the 1,093 women surveyed preferred condoms, the same amount that chose the birth control pill. Experts are happy about the figures as condoms fight off sexually transmitted diseases and pregnancy. About half of those who use condoms refer to their desire to not contract STIs as their reason for use. 50% of the 2,557 people questioned in the United Kingdom said TV programs and commercials had informed them...

2009-10-16 06:45:00

MOUNTAIN VIEW, Calif., Oct. 16 /PRNewswire/ -- Based on its annual assessment of companies making innovative contributions in healthcare, Frost & Sullivan recognizes Agile Therapeutics, Inc. (Agile) with the 2009 North American Pharmaceuticals & Biotechnology Healthcare Innovation of the Year Award for its outstanding achievements in drug development. Agile's lead product, AG200-15 with SKINFUSION(TM), offers great potential as a convenient contraceptive option. Not only does this...

2009-10-01 07:30:00

PARIS, October 1 /PRNewswire/ -- HRA Pharma (http://www.hra-pharma.com), a privately-held, European pharmaceutical company that designs products, devices and supporting services in reproductive health and endocrinology, announced today that ellaOne(R) (ulipristal acetate, 30mg), its new generation emergency contraceptive, has been launched in France, Germany and the United Kingdom via local HRA teams. HRA Pharma will progressively launch ellaOne in all European countries over the coming...

Word of the Day
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'